Cite
HARVARD Citation
Anton, A. et al. (2020). Use of prostate‐specific membrane antigen positron‐emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer. BJU international. pp. 433-435. [Online].